NeoGenomics, Inc. (NEO)

NeoGenomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	154.72	367.01	342.49	263.18	316.83	228.71
Short-Term Investments	8.96	19.83	72.72	174.81	198.56	67.55
Cash & Short-Term Investments	163.69	386.84	415.2	437.99	515.39	296.26
Cash Growth	-57.80%	-6.83%	-5.20%	-15.02%	73.97%	71.23%
Receivables	153.63	150.64	131.26	121.61	113.87	108.49
Inventory	34.17	26.75	24.16	24.28	23.4	29.53
Prepaid Expenses	22.83	20.17	17.99	15.24	12.35	11.55
Other Current Assets	18.24	11.62	8.2	6.18	16.5	2.91
Total Current Assets	392.55	596.02	596.81	605.29	681.51	448.73
Property, Plant & Equipment	168.33	173.69	183.78	198.61	211.66	131.66
Long-Term Investments	-	-	-	-	-	29.56
Goodwill	524.14	522.77	522.77	522.77	527.12	211.08
Other Intangible Assets	301.8	339.68	373.13	408.26	442.33	120.65
Long-Term Accounts Receivable	-	-	-	0.03	0.24	0.29
Long-Term Deferred Charges	0.04	0.01	0.05	0.72	0.88	0.97
Other Long-Term Assets	7.08	5.88	4.69	4.36	6.05	45.39
Total Assets	1,394	1,638	1,681	1,740	1,870	988.33
Accounts Payable	27.49	21.61	20.33	20.51	17.92	24.97
Accrued Expenses	67.04	75.07	68.23	55.21	53.1	36.38
Current Portion of Long-Term Debt	-	200.78	-	0.07	1.14	2.84
Current Portion of Leases	4.05	3.38	5.61	6.58	6.88	4.97
Current Unearned Revenue	1.08	0.41	2.13	7.56	5.19	4.03
Other Current Liabilities	0.46	-	-	-	3	-
Total Current Liabilities	100.12	301.24	96.3	89.93	87.23	73.18
Long-Term Debt	341.1	340.34	538.2	535.32	532.48	169.09
Long-Term Leases	66.62	60.84	67.87	68.95	72.29	42.3
Long-Term Unearned Revenue	0.44	0.34	-	0.02	0.92	0.71
Long-Term Deferred Tax Liabilities	19.98	21.51	24.29	34.75	55.48	5.42
Other Long-Term Liabilities	11.66	11.44	13.03	13.04	13.11	3.34
Total Liabilities	539.91	735.7	739.69	742.01	761.5	294.04
Common Stock	0.13	0.13	0.13	0.13	0.12	0.11
Additional Paid-In Capital	1,251	1,228	1,190	1,161	1,124	701.36
Retained Earnings	-396.8	-325.78	-247.06	-159.09	-14.84	-7.19
Comprehensive Income & Other	0.03	-0.21	-1.67	-3.9	-0.64	0.01
Total Common Equity	854.04	902.34	941.54	998.02	1,108	694.29
Shareholders' Equity	854.04	902.34	941.54	998.02	1,108	694.29
Total Liabilities & Equity	1,394	1,638	1,681	1,740	1,870	988.33
Total Debt	411.76	605.33	611.68	610.93	612.79	219.19
Net Cash (Debt)	-248.08	-218.49	-196.48	-172.94	-97.4	77.07
Net Cash Growth	-	-	-	-	-	102.06%
Net Cash Per Share	-1.95	-1.73	-1.57	-1.39	-0.81	0.69
Filing Date Shares Outstanding	129.18	128.46	127.61	127.46	124.03	116.94
Total Common Shares Outstanding	128.68	128.15	127.37	126.91	124.11	112.08
Working Capital	292.43	294.78	500.51	515.36	594.28	375.55
Book Value Per Share	6.64	7.04	7.39	7.86	8.93	6.19
Tangible Book Value	28.1	39.89	45.64	67	138.84	362.56
Tangible Book Value Per Share	0.22	0.31	0.36	0.53	1.12	3.23
Land	-	-	-	-	-	3.17
Buildings	-	-	-	-	-	7.4
Machinery	-	147.43	142.03	136.88	127.95	103.5
Construction In Progress	-	8.51	3.61	8.98	12.4	6.29
Leasehold Improvements	-	57.57	49.23	44.42	43.25	27.69

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q